Metrics as of 10/13/2026, 06:49 PM (Berlin time), refresh in progress.
Tilray Brands Stock
Tilray Brands, Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- CEO
- Irwin David Simon
- Employees
- 3,595
- Market cap
- $519 M
- IPO
- 05/05/2021
Tilray Brands, Inc. operates as a global enterprise deeply involved in the entire lifecycle of cannabis products, from initial research and cultivation to manufacturing, marketing, and distribution. Its reach extends across a multitude of international markets, including Canada, the United States, Europe, Australia,…
Tilray Brands stock: price history
1D
-7.6%
1W
-13.4%
1M
-16.4%
6M
-51.1%
YTD
-62.5%
1Y
-80.5%
2Y
-79.2%
5Y
-96.4%
10Y
–
Next earnings date
Next earnings date
07/01/2027 (in 82 days)
Volatility around earnings
~37% stronger price swings than usual
Ask the agents about Tilray Brands
Analyst assessment of Tilray Brands
0
STRONG BUY
3
BUY
13
HOLD
2
SELL
0
STRONG SELL
18
TOTAL · Hold
As of: 09/10/2026
Tilray Brands stock metrics
P/E
-2.33
P/B
0.27
EV/EBITDA
-28.18
RETURN ON EQUITY
-2.6%
NET MARGIN
-16.8%
DEBT/EQUITY
0.23
DIVIDEND YIELD
0.0%
AS OF
31/08/2026
Free float & liquidity
FREE FLOAT
99.3%
FLOAT SHARES
111,019,990
AVG. DAILY VOLUME (30D)
634,974
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Tilray Brands stock
What does Tilray Brands do?
Tilray Brands, Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is Irwin David Simon, the company employs around 3,595 people.
The IPO was on 05/05/2021; the stock trades on TSX under the ticker TLRY.TO.
What do analysts say about Tilray Brands stock?
18 analysts rate the stock, the consensus is Hold (as of 09/10/2026).
This is an external assessment, not a statement by Market Jury.
When does Tilray Brands report next?
The next earnings date is 07/01/2027.
Around past earnings, price swings were roughly 37% stronger than usual.
Does Tilray Brands pay a dividend?
No, Tilray Brands currently does not pay a dividend.
Which stocks are comparable to Tilray Brands?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Tilray Brands stock analyzed?
Clicking "Analyze stock" lets five strategies assess Tilray Brands against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.